Costa Carlos

Chief People OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Sep 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$107K
Net Open-Market Flow
-$107K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2024Option exercise(M)10K$3.72$38K10K
Sep 17, 2024Sell(S)10K$10.04$103K0
Sep 16, 2024Option exercise(M)400$3.72$1K400
Sep 16, 2024Sell(S)400$10.00$4K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 17, 2024Option exercise(M)10K$088K
Sep 16, 2024Option exercise(M)400$098K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006859) within minutes of acceptance. Every field above traces to the original document. Verify it directly: